Endometrial Neoplasms
📧 Sign up to get email alerts when something new happens for Endometrial Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-29Clinical Trial Results: Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer [NA]
A completed clinical trial evaluating time restricted eating among Native Hawaiian/Pacific Islander women at risk for endometrial cancer; re…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor [Phase 1, Phase 2]
This entry provides a status update on a phase 1/2 study of Eisai's E7386 in combination with other anticancer drugs for solid tumors. The t…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition [Phase 2, Phase 3]
The update notes ongoing recruitment for the DETERMINE trial Arm 02 investigating atezolizumab in adults and pediatric/young adult patients …
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer [NA]
A completed clinical trial reports that real-time visualization of lymphatic channels improves bilateral sentinel lymph node detection in en…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) [Phase 2]
Merck completed a Phase 2 trial (MK-7684A-005) evaluating MK-7684A with or without other anticancer therapies in selected solid tumors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating COM701 in combination with BMS-986207 and nivolumab in adults with advanced solid tumors, including e…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: The Efficacy and Safety of the Postoperative Adjuvant Treatment in Patients With High-risk Stage I Endometrial Carcinoma [Phase 3]
Phase 3 trial update on postoperative adjuvant treatment for high-risk stage I endometrial carcinoma assessing efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel? [Phase 2]
Phase 2 trial investigating cediranib with paclitaxel or cediranib with olaparib for advanced endometrial cancer; status unavailable.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Pembrolizumab in Combination With Doxorubicin in Advanced, Recurrent or Metastatic Endometrial Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab plus doxorubicin in advanced, recurrent, or metastatic endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer [Phase 2]
Phase 2 clinical trial investigating durvalumab and olaparib in metastatic or recurrent endometrial cancer.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue? [NA]
A completed clinical trial evaluating whether the iKnife can differentiate normal from malignant endometrial tissue, with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-06-09Clinical Trial Update: A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial Cancer [Phase 2]
Phase 2 trial assessing sapanisertib alone or in combination with MLN1117 or paclitaxel in women with endometrial neoplasms has completed wi…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Indocyanine Green Versus Blue Dye for Detection of Sentinel Lymph Node In Endometrial Cancer [Phase 3]
A Phase 3 trial comparing Indocyanine Green to Blue Dye for detecting sentinel lymph nodes in endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers [Phase 2]
Phase 2 clinical trial update for [F-18] Fluorothymidine PET/CT imaging in pelvic cancers has completed; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2016-06-03Clinical Trial Update: Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma [Phase 2]
Phase 2 study of XL147 (SAR245408) in advanced or recurrent endometrial cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial Pathology [NA]
This is a terminated clinical trial update evaluating the Goldstein SonoBiopsy Catheter for diagnosing endometrial pathology. The study was …
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Sleep and Endometrial Cancer [NA]
Clinical trial NCT00936598 examining sleep factors in endometrial neoplasms was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-03-09Clinical Trial Update: Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy. [NA]
A clinical trial evaluated a mixture of prebiotics on the intestinal microbiota of patients undergoing abdominal radiotherapy for endometria…